MD Magazine® Staff

"The current health care reform proposal is just a beginning," says Norman Makous, MD. "This legislation addresses health coverage reform. The problem that has not been touched in the current legislation relates to how we provide medical services.

Last week, Biogen Idec announced that its oral compound BG-12 (dimethyl fumarate) achieved key milestones in clinical trials for multiple sclerosis and rheumatoid arthritis.

A variety of factors are prompting hospitals to expand coverage to provide 24/7 hospitalist care, leading to the creation of a new sub-specialty: the nocturnist. Although many programs, in an effort to recruit nocturnists, promise shorter hours, more flexible scheduling, and better pay, the lifestyle adjustment nighttime coverage requires is not for everyone.

In addition to running IPC: The Hospitalist Company, the leading provider of hospital medicine in the United States, Dr. Singer was Modern Physician's Physician Entrepreneur of the Year in 2008 and has continued to shape IPC Link, a proprietary clinical communications technology designed by hospitalists for hospitalists. His dedication to the growing field and ability to recognize the power of technology in shaping the delivery of healthcare makes him an excellent source of information when it comes to "hot topics" in hospital medicine.

Products endorsed by the Arthritis Foundation’s Ease-of-Use Commendation Program are universally accessible, which means that the products don’t have to be specially designed for people with a disability, but they should be designed in way that all consumers can use them.

New research from a plastic surgeon reveals that migraine sufferers may have another treatment option—surgery.

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that BENLYSTA™ (belimumab) met the primary endpoint in BLISS-76, the second of two pivotal phase 3 trials in seropositive patients with systemic lupus erythematosus.

Additional analysis showed that reduction and long-term maintenance of normal serum urate levels also reduced risk of future gout flares.

Cardiogenic shock continues to be a major complication of acute myocardial infarction, with in-hospital mortality approaching 70% to 80% for patients who are managed medically.

The FDA yesterday approved Invega Sustenna, an extended-release injectable suspension, for the acute and maintenance treatment of schizophrenia in adults.

Cardiogenic shock continues to be a major complication of acute myocardial infarction, with in-hospital mortality approaching 70% to 80% for patients who are managed medically.

Check out photos taken at last week's Health 2.0 Conference held in Boston.

This is an exciting time to be in the endoscopy center business. Although there are many pressures on the industry, there are also some terrific opportunities to be gained by the consistent focus in a few key areas.

Gastro-esophageal reflux disease (GERD) sufferers must take medication on a regular basis to ward off the irritating condition, and while surgical procedures have proven effective, some sufferers would rather have an option that was less invasive. There is new evidence to show that several non-surgical procedures could prove to be very successful in relieving GERD symptoms.

Aloe was mentioned by Pliny the Elder and also in the New Testament. "And there came also Nicodemus, which at the first came to Jesus by night, and brought a mixture of myrrh and aloes," (John 19:3940). It is long been in use as an herbal medicine in the Orient and Asia.

Once rare digestive disease now striking 1 in 133 Americans

The new edition of Pharmacotherapy: A Pathophysiologic Approach is a recommended reference book for pharmacists.